Scientific Advances in Thoracic Oncology 2016

Ross A. Soo, Emily C.A. Stone, K. Michael Cummings, James R. Jett, John K. Field, Harry J.M. Groen, James L. Mulshine, Yasushi Yatabe, Lukas Bubendorf, Sanja Dacic, Ramon Rami-Porta, Frank C. Detterbeck, Eric Lim, Hisao Asamura, Jessica Donington, Heather A. Wakelee, Yi Long Wu, Kristin Higgins, Suresh Senan, Benjamin SolomonDong Wan Kim, Melissa Johnson, James C.H. Yang, Lecia V. Sequist, Alice T. Shaw, Myung Ju Ahn, Daniel B. Costa, Jyoti D. Patel, Leora Horn, Scott Gettinger, Solange Peters, Murry W. Wynes, Corinne Faivre-Finn, Charles M. Rudin, Anne Tsao, Paul Baas, Ronan J. Kelly, Natasha B. Leighl, Giorgio V. Scagliotti, David R Gandara, Fred R. Hirsch, David R. Spigel

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

Original languageEnglish (US)
Pages (from-to)1183-1209
Number of pages27
JournalJournal of Thoracic Oncology
Volume12
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Immunotherapy
Lung Neoplasms
Thorax
Molecular Targeted Therapy
Adjuvant Radiotherapy
Molecular Pathology
Quality of Health Care
Mesothelioma
Phosphotransferases
Therapeutics
Research
Neoplasms

Keywords

  • Adjuvant therapy
  • Biomarkers
  • Cancer prevention
  • Immunotherapy
  • Malignant mesothelioma
  • Molecular diagnostics
  • NSCLC
  • Pathology
  • Radiotherapy
  • SCLC
  • Screening
  • Smoking cessation
  • Staging
  • Surgery
  • Targeted therapy
  • Value of therapy

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Soo, R. A., Stone, E. C. A., Cummings, K. M., Jett, J. R., Field, J. K., Groen, H. J. M., ... Spigel, D. R. (2017). Scientific Advances in Thoracic Oncology 2016. Journal of Thoracic Oncology, 12(8), 1183-1209. https://doi.org/10.1016/j.jtho.2017.05.019

Scientific Advances in Thoracic Oncology 2016. / Soo, Ross A.; Stone, Emily C.A.; Cummings, K. Michael; Jett, James R.; Field, John K.; Groen, Harry J.M.; Mulshine, James L.; Yatabe, Yasushi; Bubendorf, Lukas; Dacic, Sanja; Rami-Porta, Ramon; Detterbeck, Frank C.; Lim, Eric; Asamura, Hisao; Donington, Jessica; Wakelee, Heather A.; Wu, Yi Long; Higgins, Kristin; Senan, Suresh; Solomon, Benjamin; Kim, Dong Wan; Johnson, Melissa; Yang, James C.H.; Sequist, Lecia V.; Shaw, Alice T.; Ahn, Myung Ju; Costa, Daniel B.; Patel, Jyoti D.; Horn, Leora; Gettinger, Scott; Peters, Solange; Wynes, Murry W.; Faivre-Finn, Corinne; Rudin, Charles M.; Tsao, Anne; Baas, Paul; Kelly, Ronan J.; Leighl, Natasha B.; Scagliotti, Giorgio V.; Gandara, David R; Hirsch, Fred R.; Spigel, David R.

In: Journal of Thoracic Oncology, Vol. 12, No. 8, 01.08.2017, p. 1183-1209.

Research output: Contribution to journalReview article

Soo, RA, Stone, ECA, Cummings, KM, Jett, JR, Field, JK, Groen, HJM, Mulshine, JL, Yatabe, Y, Bubendorf, L, Dacic, S, Rami-Porta, R, Detterbeck, FC, Lim, E, Asamura, H, Donington, J, Wakelee, HA, Wu, YL, Higgins, K, Senan, S, Solomon, B, Kim, DW, Johnson, M, Yang, JCH, Sequist, LV, Shaw, AT, Ahn, MJ, Costa, DB, Patel, JD, Horn, L, Gettinger, S, Peters, S, Wynes, MW, Faivre-Finn, C, Rudin, CM, Tsao, A, Baas, P, Kelly, RJ, Leighl, NB, Scagliotti, GV, Gandara, DR, Hirsch, FR & Spigel, DR 2017, 'Scientific Advances in Thoracic Oncology 2016', Journal of Thoracic Oncology, vol. 12, no. 8, pp. 1183-1209. https://doi.org/10.1016/j.jtho.2017.05.019
Soo RA, Stone ECA, Cummings KM, Jett JR, Field JK, Groen HJM et al. Scientific Advances in Thoracic Oncology 2016. Journal of Thoracic Oncology. 2017 Aug 1;12(8):1183-1209. https://doi.org/10.1016/j.jtho.2017.05.019
Soo, Ross A. ; Stone, Emily C.A. ; Cummings, K. Michael ; Jett, James R. ; Field, John K. ; Groen, Harry J.M. ; Mulshine, James L. ; Yatabe, Yasushi ; Bubendorf, Lukas ; Dacic, Sanja ; Rami-Porta, Ramon ; Detterbeck, Frank C. ; Lim, Eric ; Asamura, Hisao ; Donington, Jessica ; Wakelee, Heather A. ; Wu, Yi Long ; Higgins, Kristin ; Senan, Suresh ; Solomon, Benjamin ; Kim, Dong Wan ; Johnson, Melissa ; Yang, James C.H. ; Sequist, Lecia V. ; Shaw, Alice T. ; Ahn, Myung Ju ; Costa, Daniel B. ; Patel, Jyoti D. ; Horn, Leora ; Gettinger, Scott ; Peters, Solange ; Wynes, Murry W. ; Faivre-Finn, Corinne ; Rudin, Charles M. ; Tsao, Anne ; Baas, Paul ; Kelly, Ronan J. ; Leighl, Natasha B. ; Scagliotti, Giorgio V. ; Gandara, David R ; Hirsch, Fred R. ; Spigel, David R. / Scientific Advances in Thoracic Oncology 2016. In: Journal of Thoracic Oncology. 2017 ; Vol. 12, No. 8. pp. 1183-1209.
@article{546de1f0fa464f4eabc366614595f2f3,
title = "Scientific Advances in Thoracic Oncology 2016",
abstract = "Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.",
keywords = "Adjuvant therapy, Biomarkers, Cancer prevention, Immunotherapy, Malignant mesothelioma, Molecular diagnostics, NSCLC, Pathology, Radiotherapy, SCLC, Screening, Smoking cessation, Staging, Surgery, Targeted therapy, Value of therapy",
author = "Soo, {Ross A.} and Stone, {Emily C.A.} and Cummings, {K. Michael} and Jett, {James R.} and Field, {John K.} and Groen, {Harry J.M.} and Mulshine, {James L.} and Yasushi Yatabe and Lukas Bubendorf and Sanja Dacic and Ramon Rami-Porta and Detterbeck, {Frank C.} and Eric Lim and Hisao Asamura and Jessica Donington and Wakelee, {Heather A.} and Wu, {Yi Long} and Kristin Higgins and Suresh Senan and Benjamin Solomon and Kim, {Dong Wan} and Melissa Johnson and Yang, {James C.H.} and Sequist, {Lecia V.} and Shaw, {Alice T.} and Ahn, {Myung Ju} and Costa, {Daniel B.} and Patel, {Jyoti D.} and Leora Horn and Scott Gettinger and Solange Peters and Wynes, {Murry W.} and Corinne Faivre-Finn and Rudin, {Charles M.} and Anne Tsao and Paul Baas and Kelly, {Ronan J.} and Leighl, {Natasha B.} and Scagliotti, {Giorgio V.} and Gandara, {David R} and Hirsch, {Fred R.} and Spigel, {David R.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.jtho.2017.05.019",
language = "English (US)",
volume = "12",
pages = "1183--1209",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "8",

}

TY - JOUR

T1 - Scientific Advances in Thoracic Oncology 2016

AU - Soo, Ross A.

AU - Stone, Emily C.A.

AU - Cummings, K. Michael

AU - Jett, James R.

AU - Field, John K.

AU - Groen, Harry J.M.

AU - Mulshine, James L.

AU - Yatabe, Yasushi

AU - Bubendorf, Lukas

AU - Dacic, Sanja

AU - Rami-Porta, Ramon

AU - Detterbeck, Frank C.

AU - Lim, Eric

AU - Asamura, Hisao

AU - Donington, Jessica

AU - Wakelee, Heather A.

AU - Wu, Yi Long

AU - Higgins, Kristin

AU - Senan, Suresh

AU - Solomon, Benjamin

AU - Kim, Dong Wan

AU - Johnson, Melissa

AU - Yang, James C.H.

AU - Sequist, Lecia V.

AU - Shaw, Alice T.

AU - Ahn, Myung Ju

AU - Costa, Daniel B.

AU - Patel, Jyoti D.

AU - Horn, Leora

AU - Gettinger, Scott

AU - Peters, Solange

AU - Wynes, Murry W.

AU - Faivre-Finn, Corinne

AU - Rudin, Charles M.

AU - Tsao, Anne

AU - Baas, Paul

AU - Kelly, Ronan J.

AU - Leighl, Natasha B.

AU - Scagliotti, Giorgio V.

AU - Gandara, David R

AU - Hirsch, Fred R.

AU - Spigel, David R.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

AB - Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

KW - Adjuvant therapy

KW - Biomarkers

KW - Cancer prevention

KW - Immunotherapy

KW - Malignant mesothelioma

KW - Molecular diagnostics

KW - NSCLC

KW - Pathology

KW - Radiotherapy

KW - SCLC

KW - Screening

KW - Smoking cessation

KW - Staging

KW - Surgery

KW - Targeted therapy

KW - Value of therapy

UR - http://www.scopus.com/inward/record.url?scp=85030094918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030094918&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2017.05.019

DO - 10.1016/j.jtho.2017.05.019

M3 - Review article

C2 - 28579481

AN - SCOPUS:85030094918

VL - 12

SP - 1183

EP - 1209

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 8

ER -